Shire Stock Rating Reaffirmed by BNP Paribas (SHP)
Shire (LON:SHP)‘s stock had its “outperform” rating restated by BNP Paribas in a research note issued on Monday, Analyst Ratings News reports. They currently have a GBX 2,800 ($45.30) target price on the stock. BNP Paribas’ price objective would indicate a potential upside of 0.86% from the company’s current price.
Shares of Shire (LON:SHP) traded up 0.58% during mid-day trading on Monday, hitting GBX 2776.00. 2,069,210 shares of the company’s stock traded hands. Shire has a 52-week low of GBX 1682.00 and a 52-week high of GBX 2602.00. The stock has a 50-day moving average of GBX 2467. and a 200-day moving average of GBX 2227.. The company’s market cap is £15.318 billion.
SHP has been the subject of a number of other recent research reports. Analysts at RBC Capital raised their price target on shares of Shire from GBX 114 ($1.84) to GBX 122 ($1.97) in a research note to investors on Friday, October 18th. They now have a “sector perform” rating on the stock. Separately, analysts at AlphaValue reiterated a “reduce” rating on shares of Shire in a research note to investors on Thursday, October 17th. They now have a GBX 2,376 ($38.44) price target on the stock. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Shire in a research note to investors on Tuesday, October 15th. They now have a GBX 2,515 ($40.69) price target on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of GBX 2,135.76 ($34.55).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.